Decreased calcium pump expression in human erythrocytes is connected to a minor haplotype in the ATP2B4 gene. by Zámbó, Boglárka et al.
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Plasma  membrane  Ca2+-ATPases  are  key  calcium  exporter  proteins  in most  tissues,  and  PMCA4b  is  the
main  calcium  transporter  in  the human  red  blood  cells  (RBCs).  In  order  to assess  the  expression  level of
PMCA4b,  we  have  developed  a ﬂow  cytometry  and speciﬁc  antibody  binding  method  to  quantitatively
detect  this  protein  in  the  erythrocyte  membrane.  Interestingly,  we  found  several  healthy  volunteers
showing  signiﬁcantly  reduced  expression  of  RBC-PMCA4b.  Western  blot  analysis  of  isolated  RBC mem-
branes  conﬁrmed  this  observation,  and  indicated  that  there  are  no  compensatory  alterations  in other
PMCA  isoforms.  In  addition,  reduced  PMCA4b  levels  correlated  with  a  lower  calcium  extrusion  capacity
in these  erythrocytes.  When  exploring  the potential  genetic  background  of  the  reduced  PMCA4b  levels,
we  found  no missense  mutations  in  the  ATP2B4  coding  regions,  while  a formerly  unrecognized  minorromoter
rythrocytes
a2+
haplotype  in the  predicted  second  promoter  region  closely  correlated  with  lower  erythrocyte  PMCA4b
protein  levels.  In recent  GWA  studies,  SNPs  in  this  ATP2B4  haplotype  have  been  linked  to  reduced  mean
corpuscular  hemoglobin  concentrations  (MCHC),  and  to  protection  against  malaria  infection.  Our  data
suggest that  an  altered  regulation  of  gene  expression  is  responsible  for  the  reduced  RBC-PMCA4b  levels
that  is probably  linked  to the  development  of  human  disease-related  phenotypes.
© 2017  Elsevier  Ltd. All  rights  reserved.. Introduction
Plasma membrane Ca2+-ATPases (PMCAs) are key calcium
xporters in most human cells, and these transporters are responsi-
le for maintaining the low concentrations of cytoplasmic calcium,
ssential to calcium dependent signal transduction events. There
re four isoforms of the PMCA proteins in the human body, and
hese isoforms and their several alternative transcript variants
how tissue dependent occurrences [1]. PMCA1 and PMCA4 are
biquitous; PMCA1 is essential for the survival of the embryos,Please cite this article in press as: B. Zámbó, et al., Decreased calcium 
haplotype in the ATP2B4 gene, Cell Calcium (2017), http://dx.doi.org/1
hile the lack of PMCA4, the main calcium efﬂux protein in sperms,
esults in male infertility [2,3]. The rapidly activated PMCA2 and
∗ Corresponding author at: Institute of Enzymology, Research Centre for Natural
ciences, Hungarian Academy of Sciences, Magyar Tudosok krt. 2, Budapest, 1117,
ungary.
E-mail address: sarkadi@biomembrane.hu (B. Sarkadi).
ttp://dx.doi.org/10.1016/j.ceca.2017.02.001
143-4160/© 2017 Elsevier Ltd. All rights reserved.PMCA3 transporters are predominantly present in the nervous sys-
tem and muscle [4].
The ATP2B4 gene encodes the PMCA4 protein with potentially
8 alternative transcript variants, resulting from the combinations
of three splice sites [1]. The N-terminal splice site (A) results in
the exclusion or inclusion of exon 8, and the formation of the
z and x variants, respectively. The in vivo veriﬁcation of the B
splice site, potentially causing the exclusion of 38 amino acids
from the protein, is controversial. The C-terminal alternative splice
site (C) results in PMCA4 proteins with variable length in the
C-terminal regulatory part. The PMCA4a protein has a shorter
C-terminus, while the longer C-terminal region of the PMCA4b con-
tains regulatory sites, including a calmodulin-binding region, a PKA
phosphorylation site, a di-leucine motif and a PDZ-binding domain
[5]. At low cytoplasmic calcium concentrations the active site of
2+pump expression in human erythrocytes is connected to a minor
0.1016/j.ceca.2017.02.001
the PMCA4b protein is inhibited by the C-terminal tail, while Ca -
calmodulin binding causes tail detachment and the activation of the
transporter. The PMCA4 variants show different tissue distribution,
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nd in the RBCs the main variant is PMCA4b, while low levels of the
MCA1 protein were also found to be present [1].
Recently we have developed a ﬂow cytometry and antibody
ased method for the quantitative determination of protein levels
n the RBC membrane. This method allows the rapid determination
f numerous membrane proteins from a drop of blood (see [6]).
mong several, potentially disease-related membrane proteins, we
ave also routinely determined the level of the relatively abundant
BC membrane PMCA4b protein, as a potential internal control,
y using the PMCA4b variant speciﬁc JA3 antibody (see Methods).
nterestingly, we found several healthy volunteers with signiﬁ-
antly lower PMCA4b expression than the average values in the
eneral population. The current report describes the exploration of
he genetic background of this phenomenon, with a potential effect
n health-related phenotypes.
. Methods
.1. RBC membrane protein studies
Blood samples obtained from 155 healthy volunteers were
ncluded in these measurements (this research was approved by
he Hungarian ethics committee, ETTT). RBC membrane protein
eterminations were carried out according to our recently devel-
ped method [6–9]. In brief, we ﬁxed and permeabilized the RBC
embranes by using 1% formaldehyde solution, resulting in RBC
ghosts”, and then equal number of cells were incubated with the
MCA-speciﬁc primary antibody (JA3, mouse monoclonal antibody,
RID: AB 628160) followed by a secondary, Alexa Fluor 488 labeled
oat anti-mouse (H + L) antibody (Thermo Fisher/Life Technolo-
ies), in 96 well plates. We  found that in these ﬂow cytometry
tudies the PMCA4b speciﬁc JA3 monoclonal antibody gave the
est RBC membrane labeling efﬁciency, while the JA9 mAb  (rec-
gnizing both PMCA4 isoforms, RRID: AB 303296) and the 5F10
Ab  (recognizing all PMCA variants, RRID: AB 303334) were less
fﬁcient. Cellular ﬂuorescence was measured by FACSCanto II ﬂow
ytometer, equipped with plate loader.
Isolated human RBC membranes were prepared from 4 mL
lood according to the protocol described in [10–12], and West-
rn blots were carried out as described in [13–15]. Equal amounts
f protein (determined by Lowry method) were loaded onto 7.5%
crylamide gels, electrophoresed, transferred onto PVDF mem-
ranes and immunostained. The following primary antibodies were
sed: mouse monoclonal antibodies anti-pan PMCA (5F10, RRID:
B 303334, dilution 1:100), anti-PMCA4 (JA9, RRID: AB 303296,
ilution 1:250), and anti-PMCA4b (JA3, RRID: AB 628160, dilu-
ion 1:1500) and a rabbit polyclonal anti-PMCA1 antibody (NR1,
ilution 1:500, [15]). Subsequently, HRP-conjugated anti-mouse or
nti-rabbit secondary antibodies (Jackson ImmunoResearch) were
pplied and detected by Pierce ECL Western Blotting Substrate
Thermo Scientiﬁc) and luminography. The ImageJ 1.50i software
as used for densitometry analysis.
.2. Calcium transport measurements in RBCs
The activity of the PMCA in RBCs was analysed by Fluo-4 ﬂu-
rescence based calcium inﬂux measurements according to Ref.
16], with slight modiﬁcations. In brief, intact RBCs were suspended
n a high KCl buffer solution (10 mM HEPES, 70 mM NaCl, 80 mM
Cl, 10 mM Inosine, 5 mM piruvate, 0.15 mM MgCl2, 0.1 mM EGTA,
H7.4) and Fluo-4-AM (Molecular Probes/Invitrogen) was addedPlease cite this article in press as: B. Zámbó, et al., Decreased calcium 
haplotype in the ATP2B4 gene, Cell Calcium (2017), http://dx.doi.org/1
n a ﬁnal concentrations of 1 M.  RBCs were incubated for 1 h
t 37 ◦C, and then 5 L of the Fluo-4-loaded RBCs was added to
00 L of a Ca2+ containing medium (10 mM HEPES, 70 mM NaCl,
0 mM KCl, 5 mM Inosine, 5 mM Glucose, 0.15 mM MgCl2, 150 M PRESS
 xxx (2017) xxx–xxx
CaCl2, pH 7.4) buffer on ice. The ﬂow cytometry measurements
were started by transferring the samples to room temperature
and adding 0.8 M ﬁnal concentration of ionomycin (Molecular
Probes/Invitrogen), then following RBC ﬂuorescence by continuous
sampling for 15 min. The area under the curve (AUC) was  deter-
mined with integral calculation after normalization of the t0 Fluo-4
ﬂuorescence to zero (OriginPro 8 software).
2.3. Genetic analysis
Genomic DNA was puriﬁed from 300 L of EDTA anticoagu-
lated blood with Puregene Blood Kit (Qiagen). For sequencing the
exons and exon-intron boundary regions of the ATP2B4 gene, DNA
was ampliﬁed by standard PCR method by using the respective
primers (see Supplement Table S1), Sanger-sequencing was carried
out by the Microsynth Company. TaqMan-based qPCR reactions for
SNP detection were carried out in a StepOnePlus device (Applied
Biosystems) with premade assay mixes (cat. 4351379) and master
mix  (cat. 4371353) from Thermo Fisher/Life Technologies. TaqMan
probe speciﬁcity was veriﬁed with sequencing.
3. Results
3.1. PMCA4b protein levels in the RBC membrane
We  quantiﬁed the level of PMCA4b expression in the RBC mem-
brane of 155 healthy volunteers by ﬂow cytometry (FACS) using
the PMCA4b speciﬁc JA3 monoclonal antibody. In these experi-
ments we  found a number of volunteers with signiﬁcantly lower
than average PMCA expression levels (see Fig. 1A).
In order to conﬁrm these data, the level of PMCA4b expression in
the RBC membrane of selected individuals was  also determined by
Western blotting. This analysis showed similar PMCA expression
patterns in all types of samples except that some particular volun-
teers had a signiﬁcantly lower PMCA4b protein expression (Fig. 1B),
in good correlation with the FACS results. We  have also examined if
there was a compensatory increase in the PMCA1 protein in the low
RBC-PMCA4 membrane samples, but found no signiﬁcant changes
in this respect (see Fig. 1B).
3.2. Decreased expression of the PMCA4b causes reduced calcium
extrusion in RBCs
In order to investigate if the reduced PMCA4b protein levels
had any signiﬁcant effect on the calcium homeostasis of the RBCs,
we examined the calcium efﬂux properties of Fluo-4 loaded RBCs
after stimulating calcium entry with ionomycin (see Methods and
[16]). Fluo-4 loaded RBCs were placed into a medium with a rela-
tively low concentration (150 M)  of Ca2+, and then calcium entry
was stimulated by the addition of 0.8 M ionomycin. Using this
method we  were able to detect the intracellular calcium concen-
tration in real time in live RBCs, and measured the response of
the PMCA proteins to the elevated intracellular calcium concen-
tration. Although, PMCAs are the only Ca2+ extrusion mechanisms
in RBCs (PMCA4b being the most abundant isoform) that could
actively eliminate Ca2+ from the cytosol [17], multiple ion chan-
nels and/or Ca2+ buffering proteins may  potentially interfere with
the assay. The results of three representative experiments in Fig. 1C
show that RBCs expressing medium levels of PMCA4b are capable to
compensate for the ionophore-induced calcium inﬂux. In contrast,
RBCs from volunteers with reduced PMCA4b levels showed reduced
ability to compensate for the ionophore-induced rise in cellularpump expression in human erythrocytes is connected to a minor
0.1016/j.ceca.2017.02.001
calcium, most probably because of the reduced calcium efﬂux abil-
ity of these cells. These results suggest that changes in PMCA4b
abundance by itself can effectively inﬂuence intracellular calcium
levels in RBCs. The calculated area under the curve (AUC) showed
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Fig. 1. Expression of the PMCA4b protein in the red blood cells of healthy volunteers.
(A)  Distribution of PMCA4b protein levels as measured by quantitative ﬂow cytometry (see Methods) in 155 healthy volunteers. Samples from individuals, which were further
analysed are highlighted (K + donor number). (B) Reduced PMCA4b protein levels observed by quantitative ﬂow cytometry correspond to lower plasma membrane expression
of  this protein as measured by Western blotting. Total PMCA levels (PMCAs) were assessed by using the 5F10 monoclonal antibody, recognizing all isoforms, while the levels
of  PMCA4 isoforms were assessed by isoform-speciﬁc antibodies (see Methods). (C) Reduced RBC-PMCA4b levels result in an impaired calcium pump activity in Fluo-4 loaded
RBCs.  Fluo-4 loaded RBCs were placed into a medium containing 150 M of free calcium, and then calcium inﬂux was induced by 0.8 M ionomycin (see Methods). Under
these  conditions RBCs of most individuals were capable to down-regulate cellular calcium levels, while RBCs from donors with reduced PMCA4b levels showed impaired
c  volun
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galcium extrusion. These experiments were performed altogether in seven healthy
omozygous volunteers for Haplotype 1. Independent samples from volunteers K03
epresent the standard deviations of these three independent measurements with t
hat RBCs with low PMCA4b abundance (AUCK007 = 7.56 ± 0.33 and
UCK172 = 7.99 ± 2.75) have an about 1.58–1.67 fold higher over-
ll Ca2+ levels, compared to that in the control RBCs with average
evel of PMCA4b (AUCK030 = 4.79 ± 0.37). Thus, a reduced PMCA4b
evel may  directly impair calcium homeostasis in the RBCs of these
therwise healthy volunteers.
.3. A minor haplotype in the ATP2B4 gene correlates withPlease cite this article in press as: B. Zámbó, et al., Decreased calcium 
haplotype in the ATP2B4 gene, Cell Calcium (2017), http://dx.doi.org/1
ecreased PMCA4b protein expression
RBC membrane protein levels may  be affected by direct
enetic alterations or by various regulatory modulations (seeteers, three volunteers not carrying Haplotype 1, and three heterozygous and one
7 and K172 were measured three times, in each case with two parallels. Error bars
rallels (AUC: area under the curve).
[6,9]). According to our previous experience, strongly reduced RBC
expression levels of the ABCG2 [7] and the ABCB6 [8] membrane
proteins were connected to speciﬁc mutations and/or polymor-
phisms in the coding genes. Therefore, we  analyzed the DNA
extracts of the blood samples of the volunteers with low RBC-
PMCA4b expression by Sanger sequencing of the ATP2B4 gene,
coding for this protein. The sequencing primers were selected to
screen all exons and exon-intron boundaries of the ATP2B4 gene.pump expression in human erythrocytes is connected to a minor
0.1016/j.ceca.2017.02.001
When sequencing the ATP2B4 genes of individuals with reduced
RBC-PMCA4b protein levels (K007 and K076) we did not ﬁnd any
mutations or polymorphisms in the coding regions. In contrast, we
Please cite this article in press as: B. Zámbó, et al., Decreased calcium pump expression in human erythrocytes is connected to a minor
haplotype in the ATP2B4 gene, Cell Calcium (2017), http://dx.doi.org/10.1016/j.ceca.2017.02.001
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Fig. 2. Haplotypes in the ATP2B4 gene and their correlation with the level of PMCA4b expression in the red blood cells of healthy volunteers.)
(A)  Haplotype/SNP localizations in the ATP2B4 gene. The two isoforms of the PMCA4 protein, 4a and 4b, which are different in their C-terminal regulatory regions, result
from  alternative transcript variants. (B) Left side: Relative expression levels of RBC-PMCA4b (155 samples) and the respective Haplotypes – lower PMCA4b protein levels in
the  RBCs are closely correlated with the presence of the minor variant of Haplotype 1.
Minor allele homozygotes: red, minor allele heterozygotes: yellow, major alleles: green. Right side: Mean values +/− SD values (at least two  independent parallels), of the
PMCA4b expression levels versus the ATP2B4 genotypes (Kruskal-Wallis tests).
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Table 1
Statistical analysis of the correlation of the haplotypes and the exon 1 variant of the
ATP2B4 gene with the RBC-PMCA4b expression levels.
n = 155 healthy
subjects
p-value for correlation
with PMCA expression
(Kruskal-Wallis test)
Hardy-Weinberg eq.
(Chi-square test)
q (MAF)
Haplotype 1 p < 0.001 0.9900 0.1065
Haplotype 2 p = 0.012 (p < 0.05) 0.9113 0.4161
Haplotype 3 p = 0.040 (p < 0.05) 0.4163 0.1806
Exon 1 variant p = 0.216 (ns.) 0.9999 0.1129
Table 2
Mean RBC-PMCA4b expression levels of individuals carrying the ATP2B4 genotypes.
Genotype Mean PMCA
levels ± SD
n
Haplotype 1 (rs1541252) TT 8.1771 ± 1.0404 2
CT 12.9257 ± 1.7900 29
CC 16.4842 ± 2.2529 124
Haplotype 2 (rs955866) TT 14.5167 ± 3.1870 25
CT 15.7618 ± 2.6973 79
CC 16.2184 ± 2.3127 51
Haplotype 3 (rs3753036) AA 16.6087 ± 2.7266 2
GA 16.3905 ± 2.2263 52
GG 15.3437 ± 2.8778 101
Exon 1 variant (rs4600103) AA 15.1984 ± 2.1028 2
GA 16.5170 ± 3.1788 31ARTICLECECA-1828; No. of Pages 7
B. Zámbó et al. / Cell C
ound 7 SNPs in heterozygous forms in the non-coding regions of
hese samples, which were not present in samples with medium
BC-PMCA4b expression (K014, K030, K048, K077) (Fig. 2A). When
urther sequencing the DNA from individuals with very low RBC-
MCA4b expression levels (K110, K172) we found that the ﬁrst 5
NPs were present in a homozygous form, and the other two SNPs
ere either homozygous (K110) or heterozygous (K172). According
o the LDLink data (NIH NCBI, [18]) all these ﬁve SNPs (rs1541252,
s1541253, rs377342347, rs1419114, rs2228445) and the other
wo SNPs (rs955865, rs955866) are inherited together in haplo-
ypes (termed here by us as Haplotype 1 and Haplotype 2).
Haplotype 1 is in the 5′ region of the gene, between intron 1 to
xon 3, and a proxy analysis of rs1419114 revealed that there are
ore than 50 short variants (including insertions and deletions) in
his formerly unrecognized Haplotype, in a complete linkage dise-
uilibrium (R2 > 0.9, LDLink database). The minor allele frequency
f the variants in this Haplotype 1 in Europe is about 0.11 (NCBI
NP database). In case of Haplotype 2, proxy analysis showed that
bout 9 variants are inherited together (R2 > 0.9), but there are some
ther SNPs in the exon 20 and 3′UTR region of the gene which show
light linkage disequilibrium (0.9 > R2 > 0.2) with these variants. The
inor allele frequency of Haplotype 2 in Europe is about 0.44 (NCBI
NP database). Interestingly, Haplotypes 1 and 2 are in a weak link-
ge disequilibrium (Pearson correlation coefﬁcient R2 = 0.1505),
nd rs2228445 in Haplotype 1 shows high regulomeDB score (2b
n LDLink), and relatively high R2 coefﬁcient in proxy search with
aplotype 2 (R2 = 0.1214). These data suggest that SNP rs2228445 is
 member of both haplotypes, and has a potential role in regulating
embrane protein levels.
In addition, we have sequenced the coding region of the ATP2B4
ene in individuals showing higher RBC-PMCA4b expressions than
verage (K195, K005, K006). Studying these sequences we observed
nother haplotype (rs3753036, Haplotype 3), which overlaps the
rst haplotype, and an SNP (rs4600103), which is a variant at the
rst exon of the gene. Haplotype 3 contains at least 36 more variants
n linkage disequilibrium (R2 > 0.9), with a minor allele frequency
f 0.18 (NCBI database). The exon 1 variant shows weak (R2 < 0.8)
inkage disequilibrium with other SNPs close to its region in chro-
osome 1. The minor allele frequency of this exon 1 SNP is around
.13 in the European population. It is important to note that none
f these variants in the respective haplotypes cause any change in
he amino acid sequence of the PMCA4 protein, most of them are in
he intronic or UTR regions of the gene. The locations of the Haplo-
ype 1–3 and the exon 1 SNP in the ATP2B4 gene region are shown
n Fig. 2A.
In the following experiments we analyzed the potential cor-
elation of Haplotypes 1–3 with the RBC-PMCA4b levels. For this
urpose we set up a TaqMan assay to screen a total of 155
lood samples, in which we already had the ﬂow cytometry data
or PMCA4b expression. We  chose the rs1541252 (Haplotype 1),
s955866 (Haplotype 2), rs3753036 (Haplotype 3) as tagging SNPs
o detect Haplotype 1, 2, and 3, respectively, and examined the SNP
n exon 1 of the gene (rs4600103) as well.
The obtained results clearly show that the reduced RBC-PMCA4b
rotein levels correlate with the presence of the minor allele in
aplotype 1 (rs1541252 C > T, p < 0.001, Fig. 2B, Table 1). The sec-
nd (rs955866 C > T) and third (rs3753036 G > A) haplotypes were
nly weakly related to the PMCA4b protein levels, probably because
aplotype 2 shows a weak linkage disequilibrium with Haplotype 1
Pearson correlation coefﬁcient R2 = 0.1505), and Haplotype 3 over-
aps Haplotype 1 (Fig. 2A). The SNP in exon 1 did not show any
igniﬁcant correlation with the PMCA4b protein levels. The pres-Please cite this article in press as: B. Zámbó, et al., Decreased calcium 
haplotype in the ATP2B4 gene, Cell Calcium (2017), http://dx.doi.org/1
nce of the minor Haplotype 1 in a heterozygous (CT) form reduced
BC-PMCA4b expression by about 25%, while in a homozygous
TT) form this minor Haplotype caused a 50% expression reduc-
ion (Table 2). The Haplotype variants showed a Hardy-WeinbergGG 15.5149 ± 2.5628 122
Total 15.7112 ± 2.7060 155
equilibrium (Haplotype 1: p = 0.9900, Haplotype 2: p = 0.9113, Hap-
lotype 3: p = 0.4163, rs4600103: p = 0.9999, with Chi-square tests),
the respective MAFs (minor allele frequencies) were q(T) = 0.1065,
q(T) = 0.4161, q(A) = 0.1806, q(A) = 0.1129, in our sample set (155
samples of healthy individuals, Table 1). We  successfully validated
these results with a Sanger-sequencing of the affected ATP2B4
regions in further 22 blood samples.
4. Discussion
In this study we found that PMCA4b expression, as measured by
a ﬂow cytometry method in the RBCs of healthy donors, showed
a relatively constant average level, while in some donor RBCs the
level of this transporter protein was much lower. We  conﬁrmed
the lower PMCA4b expression levels by Western blotting in the
respective isolated RBC membranes, and showed that the lower
PMCA4b expression caused an impaired calcium efﬂux from the
RBCs.
The localization and function of integral plasma membrane pro-
teins, such as the PMCA4b protein, may  be modulated by numerous
factors, including transcriptional and translational regulation, pro-
tein trafﬁcking or membrane lipid compositions. Since PMCAs are
not glycosylated, and the plasma membrane is the only mem-
brane compartment in RBCs, the most plausible explanation for the
reduced RBC-PMCA4b expression is a transcriptional regulation.
When examining the potential genetic background of the relatively
low RBC-PMCA4b expression, we found no alterations in the coding
regions that could result in amino acid changes, or altered splicing
sequences in the ATP2B4 gene, coding for this protein. Regarding the
intronic and potential regulatory regions, our sequencing experi-
ments showed a large number of variable SNPs, potentially involved
in generating these changes in the protein expression level. We
examined the correlation of three haplotypes in the ATP2B4 genepump expression in human erythrocytes is connected to a minor
0.1016/j.ceca.2017.02.001
with the protein expression, and found that the minor allele of a
formerly unrecognized Haplotype 1 strongly correlates with low
PMCA4b expression, namely heterozygotes show about 25%, while
 ING ModelY
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omozygotes show about 50% of reduction of PMCA4b in the RBC
embrane.
According to the Eukaryotic Promoter Database (EPDnew, [19]),
here are two putative promoters in the ATP2B4 gene. The ﬁrst
romoter is located at around the ﬁrst exon, the second promoter
s around the second exon, corresponding to Haplotype 1, shown
ere to affect PMCA4b expression. Our data suggest that SNPs
n Haplotype 1 alter the binding of transcription factors which
romote PMCA4b protein expression in myeloid blood cell differ-
ntiation, thus in RBC generation. Based on the PROMO (Alggen,
20]) database, the SNPs in Haplotype 1 may  alter the binding sites
or a large number of transcription factors, including GATA-1 and
-Myb, preferentially expressed in hematopoietic lineages. Further
etailed studies are required to examine the role of the actual
ranscription factor binding sites in this region to regulate PMCA4
xpression.
Haplotype 2 is located in the 3′ UTR of the ATP2B4 gene and
hows weak correlation (R2 = 0.1505) with Haplotype 1, which may
ndicate an initial evolutionary assembly into a common haplotype.
aplotype 3 shows a partially overlapping location with Haplo-
ype 1 (Fig. 2), and the minor allele of Haplotype 3 has a weak, but
tatistically signiﬁcant effect to increase PMCA4b expression levels.
Haplotype 1 is located in a common region of the splice variants
f the ATP2B4 gene, coding both for PMCA4b and PMCA4a, thus
aplotype 1 may  affect the expression regulation of both PMCA4
sotypes. Since it is difﬁcult to obtain various human tissue samples
or measuring quantitative PMCA4 expression levels, currently we
o not know if the observed changes in the membrane PMCA lev-
ls are restricted to the RBCs or may  affect the expression level of
his protein in other tissues as well. Still, a potential correlation of
he expression regulation of PMCA4 with disease phenotypes is a
hallenging question.
The PMCA4 protein is a key calcium transporter in various sig-
aling and regulatory events. Speciﬁcally PMCA4 and PMCA1 were
hown to be involved in osteoclast function; the altered expression
f these PMCAs caused a decrease in the bone mass of menopausal
omen [21]. PMCA4a is the major calcium transporter protein in
he human sperm and has an essential role in the motility of these
ells, hence reduced PMCA4a might be involved in male sterility
2,3].
Several recent studies found potential associations between
NPs in the ATP2B4 gene, and diseases or disease-related condi-
ions, including reduced bone mass [21], increased incidence of
chizophrenia [22], cardiac hypertrophy [23], red blood cell traits
24], and the incidence of malaria infection [25]. In GWAS stud-
es the SNP rs7551442 in the ATP2B4 gene was speciﬁcally linked
o red blood cell MCHC (mean corpuscular hemoglobin concen-
ration, Ref. [24]), while SNPs rs2365860, rs10900589, rs2365858
nd rs4951074 were linked to malaria infection sensitivity [25].
hese conditions may  be linked phenotypes, e.g. impaired calcium
ump activity in the myeloid progenitors may  result in reduced RBC
emoglobin concentrations, altered cell shape and size, and in the
ature RBCs may  reduce Plasmodium infection. Plasmodium infec-
ion causes malaria, hence a reduction in Plasmodium infection may
rotect from, or ameliorate malaria. Interestingly, all these above
NPs found in the GWAS studies, are localized and thus inherited
ogether, within a formerly unrecognized Haplotype 1 of ATP2B4.
Plasmodium malariae proliferates in the erythrocytes, where the
arasite matures and multiplies within the parasitophorus vacuole
PV). This membrane vacuole is an invagination of the RBC plasma
embrane, which contains the proteins of the host erythrocyte,
ncluding PMCA4b. Recent studies [26,27] suggest that the para-Please cite this article in press as: B. Zámbó, et al., Decreased calcium 
haplotype in the ATP2B4 gene, Cell Calcium (2017), http://dx.doi.org/1
ite growth needs a sufﬁciently high calcium level in the PVs, and
hile the [Ca2+] in the RBC cytoplasm is very low, it is much higher
∼40 M)  within the PVs. Since PMCA4b is present in an inverted
ituation in the PV membrane, it pumps Ca2+ into the PV, thus gen- PRESS
 xxx (2017) xxx–xxx
erating the high Ca2+ microenvironment for the parasite. Therefore,
individuals carrying the ATP2B4 haplotype with a reduced level of
PMCA4b may  be protected against malaria due to a lower calcium
level in the PV, causing reduced proliferation of the parasite.
Here we  document a major reduction of this calcium trans-
porter protein in the RBCs of individuals carrying the minor variant
of Haplotype 1. Our studies thus establish a strong correlation
between the gene-regulation based changes in membrane PMCA
levels and the development of human disease-related phenotypes.
Based on this study, we further emphasize the advantages of the
direct measurements of RBC membrane proteins in discovering
genetic regulatory effects, and their potential in future personalized
diagnostic approaches.
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